Skip to content

Phamacokinetics of Escitalopram as a drug metabolism and transporter interaction model

Phamacokinetics of Escitalopram as a drug metabolism and transporter interaction model

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CRIS
Registry ID
KCT0000852
Enrollment
20
Registered
2013-09-26
Start date
2011-11-26
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : The aim of the present study was to measure the pharmacokinetics of escitalopram 10mg in 20 healthy male volunteers

Sponsors

Chonnam National University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Healty volunteer age between 20 to 55

Exclusion criteria

Exclusion criteria: Excessive drinker Person who took drug that can influence the experiment within 10 day before clinical trial

Design outcomes

Primary

MeasureTime frame
Cmax

Countries

Korea, Republic of

Contacts

Public ContactJai Sung Noh

Ajou University Hospital

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026